<<

CorrespondenCe Link to originaL articLe Link to author’s repLy

serious consideration. Moreover, patients who do not want to undergo preventive The forgotten and in spite of a known familial risk of Johannes Dietl and Jörg Wischhusen could be offered salpingectomy only. Based on recent results, this might afford a high degree of protection with a minimal In David D. L. Bowtell’s recent Opinion the pathogenesis of HG-SOC. This disease affect on quality of life. article (The genesis and evolution of high- accounts for the largest proportion of ovar- Johannes Dietl and Jörg Wischhusen are at the grade serous ovarian cancer. Nature Rev. ian cancers and for about two-thirds of Department for Obstetrics and , Julius- 1 Cancer 10, 803–808 (2010)) , a considerable ovarian cancer-related deaths. Maximilians-University Würzburg, School of Medicine, body of evidence is presented which further Such a revised strategy would clearly Josef-Schneider-Str. 4, 97080 Würzburg, Germany. supports the central role of the fallopian represent a paradigm change in preventive Correspondence to J.D. tube in the pathogenesis of this disease. surgery. Until recently, all debates on the e-mail: [email protected] The hypothesis that a substantial propor- aetiology and prevention of ovarian cancer doi: 10.1038/nrc2946‑c1 tion of high-grade serous ovarian cancers have focussed on the , whereas the 1. Bowtell, D. D. L. The genesis and evolution of (HG-SOC) arise from the distal fallopian fallopian tube was largely forgotten. Now, it high-grade serous ovarian cancer. Nature Rev. tube has also been proposed by several is becoming clear that clinicians must pay Cancer 10, 803–808 (2010). 2. Kindelberger, D. W. et al. Intraepithelial carcinoma 2–9 other unrelated investigations . We think due attention to the fallopian tube. Thus, of the fimbria and pelvic serous carcinoma: evidence that these findings made by molecular simultaneous risk-reducing salpingectomy for a causal relationship. Am. J. Surg. Pathol. 31, 161–169 (2007). geneticists and pathologists should now be should become the new standard whenever a 3. Carlson, J. W. et al. Serous tubal intraepithelial translated into clinical practice. The imme- needs to be carried out. carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. diate consequence for preventive medicine We also think that, based on the J. Clin. Oncol. 26, 4160–4165 (2008). would be the easy-to-carry out simultane- discussions above, the need for bilateral 4. Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M. & Vang, R. Are all pelvic (nonuterine) ous removal of the fallopian tubes during removal of the ovaries (oophorectomy) serous carcinomas of tubal origin? Am. J. Surg. surgery, such as hysterectomy (removal of should be reassessed on an individual Pathol. 34, 1407–1416 (2010). 5. Chen, E. Y. et al. Secretory cell outgrowth, PAX2 and the ) or (coagulation or basis, especially as this procedure has serous carcinogenesis in the fallopian tube. J. Pathol. partial resection of the fallopian tubes). immediate consequences for the patient. 222, 110–116 (2010). 6. Roh, M. H. et al. High-grade fimbrial-ovarian Sparing the fallopian tubes during hyster- Alarming figures from the United States carcinomas are unified by altered p53, PTEN and PAX ectomy provides no known physiological show that bilateral oophorectomy is car- expression. Mod. Pathol. 23, 1316–1324 (2010). 7. Kurman, R. J. & Shih, I.-M. The origin and pathogenesis benefits, as the remaining tubes are com- ried out in 18% of American women aged of epithelial ovarian cancer: A proposed unifying pletely devoid of any function. As the blood between 18 and 44 years old who undergo theory. Am. J. Surg. Pathol. 34, 433–443 (2010). 8. Kuhn, E. et al. Shortened telomeres in serous tubal supply to the ovaries is secured through hysterectomy for benign diseases. In intraepithelial carcinoma: an early event in ovarian vessels from the infundibulopelvic , the age group of 45 to 64 years old, this high-grade serous carcinogenesis. Am. J. Surg. Pathol. 12 34, 829–836 (2010). it is not affected when hysterectomy is proportion can be as high as 76% . Large 9. Herrington, S. S. & McCluggage, W. G. The emerging combined with bilateral removal of the fal- retrospective studies have shown that a role of the distal fallopian tube and p53 in pelvic serous carcinogenesis. J. Pathol. 220, 5–6 (2010). lopian tubes (salpingectomy). The hormone surgical menopause increases long-term 10. Sezik, M., Ozkaya, O., Demir, F., Sezik, H. T. & profile is not altered by salpingectomy, even risks for cardiovascular, psycho-sexual and Kaya, H. Total salpingectomy during abdominal 10 12 hysterectomy: effects on ovarian reserve and ovarian several months after surgery . The blind cognitive dysfunctions . Bilateral salp- stromal blood flow. J. Obstet. Gynecol. Res. 33, ending remnants of the tubes can provide ingectomy, by contrast, is not associated 863–869 (2007). 11. Ghezzi, F., Cromi, A., Siesto, G., Bergamini, V., a nidus for bacteria and thereby increase with these risks or other major side effects, Zefiro, F. & Bolis, P. Infectious morbidity after total infectious morbidity and tubal pathology but may nevertheless be most effective in laparoscopic hysterectomy: does concomitant 11 salpingectomy make a difference? BJOG 116, that can require further surgery . However, reducing or even preventing the risk for 589–593 (2009). in the light of recent findings, as discussed HG-SOC. Thus, whenever a hysterectomy 12. Hickey, M., Ambekar, M. & Hammond, I. Should the ovaries be removed or retained at the time of in Bowtell’s article, the strongest reason for needs to be carried out, simultaneous hysterectomy for benign disease? Hum. Reprod. bilateral salpingectomy or fimbriectomy risk-reducing salpingectomy can generally Update 16, 131–141 (2010). along with hysterectomy or sterilization is be recommended, whereas the case for Competing interests statement the potential role of the fallopian tube in oophorectomy should be made only after The authors declare no competing financial interests.

NATUre revIeWS | CanCer www.nature.com/reviews/cancer © 2011 Macmillan Publishers Limited. All rights reserved